Related references
Note: Only part of the references are listed.Obstructive Sleep Apnea Effects of Continuous Positive Airway Pressure on Cardiac Remodeling as Assessed by Cardiac Biomarkers, Echocardiography, and Cardiac MRI
Jane Colish et al.
CHEST (2012)
CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role?
Charalampos Mermigkis et al.
SLEEP AND BREATHING (2012)
Effects of obstructive sleep apnea and its treatment on cardiovascular risk in CAD patients
Qing Zhao et al.
RESPIRATORY MEDICINE (2011)
Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea
Luigina Guasti et al.
SLEEP AND BREATHING (2011)
C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy
Sophia E. Schiza et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Quantification of Circulating Cell-Free DNA in the Serum of Patients with Obstructive Sleep Apnea-Hypopnea Syndrome
Liang Ye et al.
LUNG (2010)
Appropriate Use of Nasal Continuous Positive Airway Pressure Decreases Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea
Katsunori Ishida et al.
CHEST (2009)
Production of Inflammatory Mediators by Monocytes in Patients with Obstructive Sleep Apnea Syndrome
Shinji Tamaki et al.
INTERNAL MEDICINE (2009)
Continuous Positive Airway Pressure Therapy Improves Hypoadiponectinemia in Severe Obese Men With Obstructive Sleep Apnea Without Changes in Insulin Resistance
Glaucia Carneiro et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2009)
Effects of Continuous Positive Airway Pressure on Cardiovascular Risk Profile in Patients With Severe Obstructive Sleep Apnea and Metabolic Syndrome
Zuzana Dorkova et al.
CHEST (2008)
Day-night variations of serum interleukin-6 in patients with severe obstructive sleep apnea syndrome before and after continuous positive airway pressure (CPAP)
Naoto Burioka et al.
CHRONOBIOLOGY INTERNATIONAL (2008)
Selective effects of CPAP on sleep apnoea-associated manifestations
A. N. Vgontzas et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea
M. A. Arias et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness
Monica de la Pena Bravo et al.
SLEEP AND BREATHING (2007)
Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome
Paschalis Steiropoulos et al.
CHEST (2007)
Decreased lipoprotein lipase in obstructive sleep apnea syndrome
Ken Iesato et al.
CIRCULATION JOURNAL (2007)
Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity
Silke Ryan et al.
THORAX (2007)
The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea
Craig L. Phillips et al.
JOURNAL OF SLEEP RESEARCH (2007)
Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea
Vincenzo Patruno et al.
CHEST (2007)
Association between polysomnographic measures of disrupted sleep and prothrombotic factors
Roland von Kanel et al.
CHEST (2007)
Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome
Ahmet Ursavas et al.
RESPIRATION (2007)
Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing
S. K. Sharma et al.
SLEEP MEDICINE (2007)
Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome
Silke Ryan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome
S Ryan et al.
CIRCULATION (2005)
Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome
O Kokturk et al.
INTERNATIONAL HEART JOURNAL (2005)
C-reactive protein levels determine systemic nitric oxide bioavailability in patients with coronary artery disease
S Fichtlscherer et al.
EUROPEAN HEART JOURNAL (2004)
C-reactive protein: Risk marker or mediator in atherothrombosis?
I Jialal et al.
HYPERTENSION (2004)
Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome
K Minoguchi et al.
CHEST (2004)
C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes
KH Han et al.
CIRCULATION (2004)
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome
TU Ciftci et al.
CYTOKINE (2004)
Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells
P Calabró et al.
CIRCULATION (2003)
Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea - Results of a meta-analysis
SR Patel et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continious positive airway pressure
T Yokoe et al.
CIRCULATION (2003)
C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells
S Devaraj et al.
CIRCULATION (2003)
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
PM Ridker
CIRCULATION (2003)
Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea - A 7-year follow-up
Y Peker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Elevated c-reactive protein in patients with obstructive sleep apnea
ASM Shamsuzzaman et al.
CIRCULATION (2002)
Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea
RS Amin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Obstructive apnea during sleep is associated with peripheral vasoconstriction
VA Imadojemu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
High-sensitivity C-reactive protein - Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
PM Ridker
CIRCULATION (2001)
Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the sleep heart health study
E Shahar et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Raised interleukin-6 levels in obese patients
L Roytblat et al.
OBESITY RESEARCH (2000)
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.
B Lindahl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
J Danesh et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Prospective study of the association between sleep-disordered breathing and hypertension
PE Peppard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
JS Yudkin et al.
ATHEROSCLEROSIS (2000)
Share Paper
